- Gary P.
Kobinger OM MSC is a
Canadian immunologist and
virologist who is
currently the
director at the
Galveston National Laboratory at the University...
- 1016/S0140-6736(20)31866-3. PMC 7471804. PMID 32896291. Fausther-Bovendo H,
Kobinger GP (2014). "Pre-existing
immunity against Ad vectors: humoral, cellular...
- Crozier, I; Dolnik, O; Dye, JM; Formenty, PBH; Griffiths, A; Hewson, R;
Kobinger, GP; Leroy, EM; Mühlberger, E; Netesov, SV; Palacios, G; Pályi, B; Pawęska...
- Hensley, Lisa E.; Honko, Anna N.; Jahrling,
Peter B.; Johnson, Karl M.;
Kobinger, Gary; Leroy, Eric M.; Lever, Mark S.; Mühlberger, Elke; Netesov, Sergey...
- Gary
Kobinger helped develop ZMapp, an
experimental biopharmaceutical drug to
treat Ebola. The
development of this drug won both Qiu and
Kobinger the 2018...
-
Software Patents,
archived from the
original on 16 June 2009 Kiesewetter-
Köbinger, Swen (2008), "Pacta sunt servanda", JurPC,
WebDok 100/2008: 5, doi:10...
-
January 2016.
Weingartl HM, Embury-Hyatt C, Nfon C,
Leung A,
Smith G,
Kobinger G (2012). "Transmission of
Ebola virus from pigs to non-human primates"...
- ****ay
using the
melting curve method.
Shahhosseini N,
Babuadze GG, Wong G,
Kobinger GP (April 2021). "Mutation
Signatures and In
Silico Docking of
Novel SARS-CoV-2...
-
Georgy M.; Jahrling,
Peter B.; Johnson, Karl M.; Klenk, Hans-Dieter;
Kobinger, Gary; Lackemeyer,
Matthew G.; Leroy, Eric M.; Lever, Mark S.; Lofts, Loreen...
-
Research Institute of
Infectious Diseases; the ****tail was
optimized by Gary
Kobinger, a
research scientist at the NML and
underwent further development under...
